Publicaciones en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (36)

2023

  1. Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy

    Kidney360, Vol. 4, Núm. 5, pp. 659-672

2022

  1. C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 11, pp. 2128-2137

  2. Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy

    Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746

  3. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280

  4. Revisión de la literatura sobre la evidencia disponible actualmente para el manejo de las queratitis infecciosas con PACK-CXL

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 8, pp. 464-472

  5. Vogt-Koyanagi-Harada disease in Spain

    European Journal of Ophthalmology, Vol. 32, Núm. 3, pp. 1547-1554

2021

  1. New Horizons in the Treatment of Corneal Endothelial Dysfunction

    Journal of Ophthalmology, Vol. 2021

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 9, pp. 438-443

  3. Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 10, pp. 3342-3347

  4. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  5. Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease

    Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298

2019

  1. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

    American Journal of Ophthalmology, Vol. 200, pp. 85-94

  2. Función visual y deficiencia visual cerebral (cerebral visual impairment) en niños: La importancia de entenderla y atenderla

    Archivos de la Sociedad Española de Oftalmologia, Vol. 94, Núm. 6, pp. 261-262

  3. Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis

    Clinica Chimica Acta, Vol. 488, pp. 135-142

2017

  1. New insights into the genetic component of non-infectious uveitis through an Immunochip strategy

    Journal of Medical Genetics, Vol. 54, Núm. 1, pp. 38-46

2016

  1. Month of birth, HLA-DRB1*15 locus and risk of multiple sclerosis in offspring

    Revista de Neurologia, Vol. 63, Núm. 5, pp. 201-205

  2. Report From the First and Second Spanish Killer Immunoglobulin-Like Receptor Genotyping Workshops: External Quality Control for Natural Killer Alloreactive Donor Selection in Haploidentical Stem Cell Transplantation

    Transplantation Proceedings

2015

  1. Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus

    Rheumatology International, Vol. 35, Núm. 5, pp. 777-785

  2. Consensus document on allergic conjunctivitis (DECA)

    Journal of Investigational Allergology and Clinical Immunology, Vol. 25, Núm. 2, pp. 94-106